Few studies found that failing hearts of humans and mice showed decreased levels of Sirt6, suggesting that low levels of Sirt6 increase the activity of IGF-Akt, leading to initiation and progression of cardiac hypertrophy and heart failure (Sundaresan et al., 2012; Zhang D. et al., 2018). Here, AKT1 is linked to cardiac hypertrophy.